The Anal Fissure Treatment Market report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market.
Pune, India -- (SBWIRE) -- 09/28/2017 -- The Anal Fissure Treatments Market report segmented on the basis of drugs and surgery. Based on drugs, the market has been segmented as topical nitroglycerin, calcium channel blockers, stool softeners, and others. Based on the surgery, the market has been segmented as lateral internal sphincterotomy, anal dilation and others. and Middle East & Africa.
Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/3841
Anal Fissure Treatments Market Regional Analysis:
US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global anal fissure treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest growing region because of large unmet needs which is led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.
Anal Fissure Treatments Market Key Players:
Key players profiled in the report are SRS Pharmaceuticals Pvt. ltd., Healthy Life Pharma Private Limited, Takeda Pharmaceutical Company Limited, Troikaa Pharmaceuticals Ltd., Novasep, Taj Pharmaceuticals Ltd., PurduePharma L.P., Geri-Care Pharmaceuticals, and others.
An anal fissure, is a break or tear in the skin of the anal canal characterised by anal bleeding and pain during and after defecation. Stretching of the anal mucosa beyond its capability due to strain of defecating and spasming of the internal anal sphincter muscle resulting in impaired blood supply to the anal mucosa are the most common causes of anal fissures. Anal fissures can get infected by faecal bacteria.
The market for anal fissures is rising due to rising cases of constipation and diarrhoea. Older patients are more affected due to decreased blood flow to the anus. The rise in cases of tuberculosis, carcinoma, acquired immunodeficiency syndrome (AIDS), inflammatory bowel disease are also important market drivers. Other drivers of anal fissures include anal sex, childbirth trauma in women, Crohn's disease, ulcerative colitis etc.
Get Discount @ https://www.marketresearchfuture.com/check-discount/3841
Considering all these factors the market for anal fissure treatment is expected to reach $ 2.6 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 5.2 % during 2017-2023.
About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.